Accession Number: | 0001209191-19-061786 |
Date: | 2019-12-19 |
Issuer: | HERON THERAPEUTICS, INC. /DE/ (HRTX) |
Original Submission Date: |
DAVIS STEPHEN
4242 CAMPUS POINT COURT
SUITE 200
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 25.02 | 2019-12-19 | deemed execution date | A | 15,500 (a) | 2029-12-19 | common stock 15,500 | $25.02 | 15,500 | direct |
ID | footnote |
---|---|
f1 | the stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. |